Fewer COVID ‐19 neurological complications with dexamethasone and remdesivir
Annals of Neurology(2022)
摘要
Treatment with dexamethasone, remdesivir, or both in patients hospitalized with COVID-19 was associated with a lower frequency of neurological complications in an additive manner, such that the greatest benefit was observed in patients who received both drugs together. ANN NEUROL 2023;93:88-102.
更多查看译文
关键词
dexamethasone,neurological complications
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要